Jane Street’s TRACON Pharmaceuticals, Inc. Common Stock TCON Stock Holding History

Jane Street’s Portfolio TCON Stock Details TCON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-9,115	Closed	-$78.4K	–	10418
2024 Q1	$78.4K	Buy	+9,115	New	+$43.5K	﹤0.01%	8619
2023 Q2	–	Sell	-849	Closed	-$32.1K	–	9799
2023 Q1	$32.1K	Buy	+849	New	+$27.8K	﹤0.01%	8559
2022 Q3	–	Sell	-503	Closed	-$20K	–	10688
2022 Q2	$20K	Sell	503 -17	-3%	-$658	﹤0.01%	9166
2022 Q1	$27K	Buy	+520	New	+$26.1K	﹤0.01%	9866
2021 Q1	–	Sell	-552	Closed	-$129K	–	9706
2020 Q4	$129K	Sell	552 -1,385	-72%	-$193K	﹤0.01%	7126
2020 Q3	$200K	Buy	+1,937	New	+$104K	﹤0.01%	6435
2019 Q2	–	Sell	-84	Closed	-$23K	–	5905
2019 Q1	$23K	Buy	+84	New	+$18.2K	﹤0.01%	4895

Other funds holding TCON

Game Plan Financial Advisors Westlake, Ohio $264M AUM 21.06% 1-Year Est. Return

Jane Street's TCON Position: Q2 2024 in Review

Jane Street sold out of TRACON Pharmaceuticals, Inc. Common Stock (TCON) in Q2 2024, closing a stake of 9,115 shares — an estimated $78.4K sold.

Jane Street first reported a position in TCON in Q1 2019 and held it in 7 quarters. The position peaked at $200K in Q3 2020. 1 fund tracked by Wall St. Rank holds TCON as of Q2 2024.

Jane Street reported no remaining TRACON Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Jane Street sold 9,115 TRACON Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $78.4K.
Jane Street first reported a position in TRACON Pharmaceuticals, Inc. Common Stock in Q1 2019 and held it in 7 quarters.
Jane Street's TRACON Pharmaceuticals, Inc. Common Stock position peaked at $200K in Q3 2020.
1 fund tracked by Wall St. Rank held TRACON Pharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on Jane Street's 13F filing for Q2 2024, filed 15 Aug 2024.